Biocon: A Credibly Capable Organization
On July 15, 2016, Biocon Ltd. announced the launch of a high quality, yet affordable biosimilar version of Sanofi's blockbuster Lantus drug for patients of diabetes in Japan. Lantus, or…
On July 15, 2016, Biocon Ltd. announced the launch of a high quality, yet affordable biosimilar version of Sanofi's blockbuster Lantus drug for patients of diabetes in Japan. Lantus, or…